The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.81 in the last session, up 0.56% from day before closing price of $0.81. In other words, the price has increased by $0.56 from its previous closing price. On the day, 1.39 million shares were traded. MCRB stock price reached its highest trading level at $0.82 during the session, while it also had its lowest trading level at $0.76.
Ratios:
We take a closer look at MCRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.38.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 28 ’24 when von Moltke Lisa sold 4,334 shares for $0.69 per share. The transaction valued at 2,991 led to the insider holds 30,423 shares of the business.
Henn Matthew R. sold 3,984 shares of MCRB for $2,749 on Oct 28 ’24. The insider now owns 75,885 shares after completing the transaction at $0.69 per share. On Oct 28 ’24, another insider, DesRosier Thomas, who serves as the Chief Legal Officer and EVP of the company, sold 4,259 shares for $0.69 each. As a result, the insider received 2,939 and left with 133,414 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 138185376 and an Enterprise Value of 264583392. For the stock, the TTM Price-to-Sale (P/S) ratio is 373.48. Its current Enterprise Value per Revenue stands at 707.442 whereas that against EBITDA is -1.746.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $2.05, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -7.58%, while the 200-Day Moving Average is calculated to be -12.62%.
Shares Statistics:
According to the various share statistics, MCRB traded on average about 3.80M shares per day over the past 3-months and 2285720 shares per day over the past 10 days. A total of 135.04M shares are outstanding, with a floating share count of 118.92M. Insiders hold about 30.13% of the company’s shares, while institutions hold 27.23% stake in the company. Shares short for MCRB as of 1728950400 were 18054013 with a Short Ratio of 4.75, compared to 1726185600 on 17215115. Therefore, it implies a Short% of Shares Outstanding of 18054013 and a Short% of Float of 14.21.
